What does it mean when a study is stopped because it didn't meet its primary endpoint?

An endpoint in a research study aims to answer a specific question. For example, the primary endpoint of a study could be whether a particular treatment is effective at stopping symptom X. Researchers will compare the reduction in symptom X between the treatment group and the placebo group.

In addition to the primary endpoint, there are also secondary outcomes which may be related to lab data. These secondary outcomes could involve comparing lab results between the treatment and placebo groups or evaluating safety data such as the number of people admitted to the hospital or the occurrence of particular side effects. These secondary outcomes also serve as endpoints in the study.

When a trial fails to reach an endpoint, it usually means that it hasn't been as effective as desired. As a result, the decision is made to discontinue the trial because the drug has not shown the required effectiveness to continue forward. Another reason for stopping a trial is safety issues.

If the trial uncovers a higher-than-expected side effect profile, it may be stopped for that reason as well. This can happen years down the line. This underlines the importance of such trials and why they can continue for a long time.

This is also why you might hear about a drug still being in a trial even ten years later.
None of this happens quickly. It can be incredibly frustrating to have a medical condition and seek treatment.

However, it's important to ensure that new drugs are thoroughly tested and safe before being released to the public. Careful management is essential to guarantee the effectiveness and safety of these new treatments.